Abstract
Epithelial–mesenchymal transition (EMT), which is characterized by the suppression of the adhesion protein E-cadherin, is a crucial process that promotes metastasis and stem-like properties of cancer cells. However, the dissociation of cellular aggregates is not sufficient to explain why cancer cells move, and the motile nature of cancer cells undergoing EMT remains elusive. Here, we identify a mechanism in which the EMT inducer Twist1 elicits cancer cell movement through activation of RAC1. Twist1 cooperates with BMI1 to suppress let-7i expression, which results in upregulation of NEDD9 and DOCK3, leading to RAC1 activation and enabling mesenchymal-mode movement in three-dimensional environments. Moreover, the suppression of let-7i contributes to Twist1-induced stem-like properties. Clinically, activation of the Twist1–let-7i–NEDD9 axis in head and neck cancer patients correlates with tumour invasiveness and worse outcome. Our results uncover an essential mechanism to explain how Twist1 induces the motile stem-like cancer cell phenotype beyond simply suppressing E-cadherin.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kalluri, R. & Weinberg, R. A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 119, 1420–1428 (2009).
Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871–890 (2009).
Mani, S. A. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704–715 (2008).
Gupta, P. B. et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138, 645–659 (2009).
Wolf, K. et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat. Cell Biol. 9, 893–904 (2007).
Friedl, P. & Wolf, K. Plasticity of cell migration: a multiscale tuning mode. J. Cell Biol. 188, 11–19 (2010).
Sanz-Moreno, V. et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell 135, 510–523 (2008).
Sanz-Moreno, V. & Marshall, C. J. The plasticity of cytoskeletal dynamics underlying neoplastic cell migration. Curr. Opin. Cell Biol. 22, 690–696 (2010).
Wyckoff, J. B., Pinner, S. E., Gschmeissner, S., Condeelis, J. S. & Sahai, E. ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr. Biol. 16, 1515–1523 (2006).
Wolf, K. et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 160, 267–277 (2003).
Yamazaki, D., Kurisu, S. & Takenawa, T. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates. Oncogene 28, 1570–1583 (2009).
Belgiovine, C. et al. Reduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cells. PLoS One 30, e14154 (2010).
Furlong, E. E., Andersen, E. C., Null, B., White, K. P. & Scott, M. P. Patterns of gene expression during Drosophila mesoderm development. Science 293, 1629–1633 (2001).
Yang, J. et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 117, 927–939 (2004).
Yang, M. H. et al. Direct regulation of TWIST by HIF-1α promotes metastasis. Nat. Cell Biol. 10, 295–305 (2008).
Yang, M. H. et al. Bmi1 is essential in Twist1-induced epithelial-mesenchymal transition. Nat. Cell Biol. 12, 982–992 (2010).
Ma, L., Teruya-Feldstein, J. & Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682–688 (2007).
Gregory, P. A. et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 10, 593–601 (2008).
Dykxhoorn, D. M. MicroRNAs and metastasis: little RNAs go a long way. Cancer Res. 70, 6401–6406 (2010).
Yu, F. et al. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131, 1109–1123 (2007).
Rybak, A. et al. A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat. Cell Biol. 10, 987–993 (2008).
Sampson, V. B. et al. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res. 67, 9762–9770 (2007).
Lee, Y. S. & Dutta, A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 21, 1025–1030 (2007).
Prince, M. E. et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc. Natl Acad. Sci. USA 104, 973–978 (2007).
Evan-Ram, S. & Yamada, K. M. Cell migration in 3D matrix. Curr. Opin. Cell Biol. 17, 524–532 (2005).
Slorach, E. M., Chou, J. & Werb, Z. Zeppo1 is a metastasis promoter that represses E-cadherin expression and regulates p120-catenin isoform expression and localization. Genes Dev. 25, 471–484 (2011).
Amano, M. et al. Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271, 20246–20249 (1996).
Croft, D. R. & Olson, M. F. Conditional regulation of a ROCK-estrogen receptor fusion protein. Methods Enzymol. 406, 541–553 (2006).
Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281–297 (2004).
Cabodi, S., del Pilar Camacho-Leal, M., Di Stefano, P. & Defilippi, P. Integrin signalling adaptors: not only figurants in the cancer story. Nat. Rev. Cancer 10, 858–870 (2010).
Namekata, K., Enokido, Y., Iwasawa, K. & Kimura, H. MOCA induces membrane spreading by activating Rac1. J. Biol. Chem. 279, 14331–14337 (2004).
Greene, F. L. et al. American Joint Committee on Cancer (AJCC) Cancer Staging Manual 6th edn 17–68 (Springer, 2002).
Ansieau, S. et al. Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14, 79–89 (2008).
Chang, C. J. et al. Let-7d functions as regulator of epithelial-mesenchymal transition and chemoresistant property in oral cancer. Oncol. Rep. 26, 1003–1010 (2011).
Peter, M. E. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 8, 843–852 (2009).
Panková, K., Rösel, D., Novotný, M. & Brábek, J. The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells. Cell Mol. Life Sci. 67, 63–71 (2010).
Garavello, W., Ciardo, A., Spreafico, R. & Gaini, R. M. Risk factors for distant metastases in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 132, 762–766 (2006).
Hsu, D. S. et al. Regulation of excision repair cross-complementation group 1 (ERCC1) by Snail contributes to cisplatin resistance in head and neck cancer. Clin. Cancer Res. 16, 4561–4571 (2010).
Huang, C. C. et al. Regulation of membrane-type 4 matrix metalloproteinase (MT4-MMP) by SLUG contributes to hypoxia-mediated metastasis. Neoplasia 11, 1371–1382 (2009).
N Namekata, K., Enokido, Y., Iwasaka, K. & Kimura, H. MOCA induces membrane spreading by activating Rac1. J. Biol. Chem. 279, 14331–14337 (2004).
E Ebert, M. S., Neilson, J. R. & Sharp, P. A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4, 721–726 (2007).
O’Hara, S. P. et al. NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPβ)-mediated transcriptional repression of microRNA let-7i following microbial infection. J. Biol. Chem. 285, 216–225 (2010).
Chen, C. et al. Real-time quantification of microRNAs by stem–loop RT–PCR. Nucleic Acids Res. 33, e179 (2005).
Pinner, S. & Sahai, E. PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE. Nat. Cell Biol. 10, 127–137 (2008).
Wilkinson, S., Paterson, H. F. & Marshall, C. J. Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion. Nat. Cell Biol. 7, 255–261 (2005).
Remmele, W. & Schicketanz, K. H. Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading (IRS). Pathol. Res. Pract. 189, 862–866 (1993).
Acknowledgements
We thank M. F. Olson (The Beaston Institute for Cancer Research, UK) for providing the ROCK–ER-WT and ROCK–ER-K121G plasmids, and H. Kimura (National Institute of Neuroscience, Tokyo, Japan) for the pCl–neo–DOCK3HA plasmid. We thank T. Z. Huang, Y. B. Khotskaya, C. W. Lee and S. S. Chang (M. D. Anderson Cancer Center, Texas, USA) for critical comments on the manuscript. We thank C. H. Lin and H. W. Liu (National Yang-Ming University, Taiwan) for supporting the time-lapse microscopy techniques. This work was supported by the National Health Research Institutes (NHRI-EX100-10037BI to M-H.Y.; NHRI-EX100-9931BI to K-J.W.); the National Science Council (NSC 99-2314-B-010-007-MY3 and 100-2321-B-010-015 to M-H.Y.; NSC 100-2321-B-039-002 to M-C.H.); Taipei Veterans General Hospital (VGH 100-C-088, 101-C-005 to M-H.Y.); Veterans General Hospitals University System of Taiwan Joint Research Program (VGHUST101-G7-4-1 to M-H.Y.); a grant from the Ministry of Education, Aim for the Top University Plan (to M-H.Y.); a grant from the Department of Health, Center of Excellence for Cancer Research (DOH100-TD-C-111-007 to M-H.Y; DOH101-TD-C-111-005 to M-C.H.); and the Sister Institution Fund of China Medical University and Hospital and MD Anderson Cancer Center.
Author information
Authors and Affiliations
Contributions
M-H.Y. and W-H.Y. conceived and designed the experiments. W-H.Y. and H-Y.L. carried out the experiments with the assistance of C-H.H for in vivo work. M-H.Y., W-H.Y. and H-Y.L. analysed the data. M-H.Y. wrote the paper with assistance from M-C.H. and K-J.W. The treatment and sample collection of HNSCC patients were carried out by S-K.T., C-H.T., S-Y.K. and M-H.Y.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary Information (PDF 1689 kb)
Supplementary Table 1
Supplementary Information (XLSX 15 kb)
Supplementary Table 2
Supplementary Information (XLSX 12 kb)
Supplementary Table 3
Supplementary Information (XLSX 12 kb)
Supplementary Table 4
Supplementary Information (XLSX 11 kb)
Supplementary Table 5
Supplementary Information (XLSX 12 kb)
Supplementary Table 6
Supplementary Information (XLSX 13 kb)
Supplementary Table 7
Supplementary Information (XLSX 12 kb)
Supplementary Movie 1
Supplementary Information (AVI 3538 kb)
Supplementary Movie 2
Supplementary Information (AVI 7439 kb)
Supplementary Movie 3
Supplementary Information (AVI 7272 kb)
Supplementary Movie 4
Supplementary Information (AVI 1953 kb)
Supplementary Movie 5
Supplementary Information (AVI 3312 kb)
Supplementary Movie 6
Supplementary Information (AVI 7792 kb)
Supplementary Movie 7
Supplementary Information (AVI 3525 kb)
Supplementary Movie 8
Supplementary Information (AVI 1528 kb)
Supplementary Movie 9
Supplementary Information (AVI 3514 kb)
Supplementary Movie 10
Supplementary Information (AVI 3165 kb)
Supplementary Movie 11
Supplementary Information (AVI 2675 kb)
Supplementary Movie 12
Supplementary Information (AVI 2272 kb)
Supplementary Movie 13
Supplementary Information (AVI 5902 kb)
Supplementary Movie 14
Supplementary Information (AVI 4525 kb)
Supplementary Movie 15
Supplementary Information (AVI 1421 kb)
Supplementary Movie 16
Supplementary Information (AVI 1956 kb)
Rights and permissions
About this article
Cite this article
Yang, WH., Lan, HY., Huang, CH. et al. RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol 14, 366–374 (2012). https://doi.org/10.1038/ncb2455
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb2455
This article is cited by
-
MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition
Journal of Experimental & Clinical Cancer Research (2023)
-
Rac1 activation in oral squamous cell carcinoma as a predictive factor associated with lymph node metastasis
International Journal of Clinical Oncology (2023)
-
The role of insulin and incretin-based drugs in biliary tract cancer: epidemiological and experimental evidence
Discover Oncology (2022)
-
Linking EMT programmes to normal and neoplastic epithelial stem cells
Nature Reviews Cancer (2021)
-
The pan-cancer landscape of crosstalk between epithelial-mesenchymal transition and immune evasion relevant to prognosis and immunotherapy response
npj Precision Oncology (2021)